Stepan Company reported a record net income of $39.4 million, or $1.71 per diluted share, for the third quarter of 2022, compared to $36.9 million, or $1.59 per diluted share, in the prior year. Adjusted net income was $46.3 million, or $2.01 per diluted share, versus $36.4 million, or $1.57 per diluted share, in the prior year. Total Company sales volume decreased 8% versus the prior year.
Surfactant operating income was $39.0 million versus $34.5 million in the prior year, driven by improved product and customer mix.
Polymer operating income was $31.9 million versus $19.8 million in the prior year, attributable to margin recovery and improved mix.
Specialty Product operating income was $9.7 million versus $2.4 million in the prior year, primarily attributable to improved margins and customer mix within the medium chain triglycerides (MCTs) product line.
The company increased its quarterly cash dividend in the fourth quarter of 2022 by $0.03 per share, or 9.0%, marking the 55th consecutive year of increased cash dividend.
The Company delivered record third quarter and nine-month results and we expect to deliver record full year earnings again in 2022.
Visualization of income flow from segment revenue to net income
Analyze how earnings announcements historically affect stock price performance